The FAM20C inhibitor, FL-1607, developed through in silico network analysis, molecular modeling, and molecular dynamics approaches, inhibited proliferation of MDA-MB-468 and MDA-MB-231 human breast cancer cell lines and increased apoptosis and inhibited migration of MDA-MB-468 cells (86). Here, FAM20C is linked to breast cancer.